Center for Scientific Review; Notice of Closed Meetings, 18658 [2017-07931]
Download as PDF
<![CDATA[
asabaliauskas on DSK3SPTVN1PROD with NOTICES
18658
Federal Register / Vol. 82, No. 75 / Thursday, April 20, 2017 / Notices
stakeholders. Please visit the NPRSB
Web site at https://www.phe.gov/nprsb
for all application submission
information and instructions. If
interested, please submit your
application by the deadline of June 7,
2017, at 11:59 p.m.
FOR FURTHER INFORMATION CONTACT: CDR
Evelyn Seel, MPH, Designated Federal
Official, National Preparedness and
Response Science Board, Office of the
Assistant Secretary for Preparedness
and Response, U.S. Department of
Health and Human Services, Thomas P.
O’Neill Federal Building, Room Number
22H11, 200 C St. SW., Washington, DC
20024; Office: 202–205–7960, Email
address: evelyn.seel@hhs.gov.
SUPPLEMENTARY INFORMATION: Pursuant
to section 319M of the Public Health
Service (PHS) Act (42 U.S.C. 247d–7f)
and section 222 of the PHS Act (42
U.S.C. 217a), the Department of Health
and Human Services (HHS) established
the NPRSB. The Board shall provide
expert advice and guidance to the
Secretary on scientific, technical, and
other matters of special interest to HHS
regarding current and future chemical,
biological, nuclear, and radiological
agents, whether naturally occurring,
accidental, or deliberate. The Board may
also provide advice and guidance to the
Secretary and/or the Assistant Secretary
for Preparedness and Response (ASPR)
on other matters related to public health
emergency preparedness and response.
Description of Duties: The Board shall
advise the Secretary and/or ASPR on
current and future trends, challenges,
and opportunities presented by
advances in biological and life sciences,
biotechnology, and genetic engineering
with respect to threats posed by
naturally occurring infectious diseases
and chemical, biological, radiological,
and nuclear agents. At the request of the
Secretary and/or ASPR, the Board shall
review and consider any information
and findings received from the working
groups established under 42 U.S.C.
247d–7f(b). At the request of the
Secretary and/or ASPR, the Board shall
provide recommendations and findings
for expanded, intensified, and
coordinated biodefense research and
development activities. The Secretary
and/or ASPR may assign additional
advisory duties concerning public
health emergency preparedness and
response at his/her discretion.
Structure: The Board shall consist of
13 voting members, including the
chairperson; additionally, there may be
non-voting ex officio members. Pursuant
to 42 U.S.C. 247d–7f(a), the Secretary
shall appoint members and the
Chairperson from among the nation’s
VerDate Sep<11>2014
17:27 Apr 19, 2017
Jkt 241001
preeminent scientific, public health,
and medical experts, as follows: (a)
Such federal officials as the Secretary
determines are necessary to support the
functions of the Board; (b) four
individuals from the pharmaceutical,
biotechnology, and device industries; (c)
four academicians; and, (d) five other
members as determined appropriate by
the Secretary and/or ASPR, one of
whom must be a practicing health care
professional, one of whom must be from
an organization representing health care
consumers, one of whom must have
pediatric subject matter expertise, and
one of whom shall be a state, tribal,
territorial, or local public health official.
The Secretary will appoint additional
members for category (d), above, from
among emergency medical responders
and organizations representing other
appropriate stakeholders. A member of
the Board described in (b), (c), or (d) in
the above paragraph shall serve for a
term of three years, except that the
Secretary may adjust the terms of the
initial Board appointees in order to
provide for a staggered term of
appointment of all members. The
Secretary shall appoint members who
are not full-time or permanent part-time
federal employees as special
government employees.
Dated: April 14, 2017.
George W. Korch Jr.,
Acting Assistant Secretary for Preparedness
and Response.
[FR Doc. 2017–08005 Filed 4–19–17; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel RFA–OD–
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
15–004—Tobacco Regulatory Sciences Small
Grant Program for New Investigators (R03).
Date: May 15, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Hotel Reston, 11810
Sunrise Valley Dr., Herndon, VA 20191.
Contact Person: Malaya Chatterjee, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6192,
MSC 7804, Bethesda, MD 20892, (301) 806–
2515, chatterm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Risk
Prevention and Health Behavior AREA
Review.
Date: May 15, 2017.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: John H. Newman, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3222,
MSC 7808, Bethesda, MD 20892, (301) 435–
0628, newmanjh@csr.nih.gov.
Name of Committee: Cell Biology
Integrated Review Group, Nuclear and
Cytoplasmic Structure/Function and
Dynamics Study Section.
Date: May 18, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn Bethesda, 7301
Waverly Street, Bethesda, MD 20814.
Contact Person: David Balasundaram,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5189,
MSC 7840, Bethesda, MD 20892, 301–435–
1022, balasundaramd@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: April 14, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–07931 Filed 4–19–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
E:\FR\FM\20APN1.SGM
20APN1
]]>Agencies
[Federal Register Volume 82, Number 75 (Thursday, April 20, 2017)]
[Notices]
[Page 18658]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-07931]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel RFA-OD-15-004--Tobacco Regulatory Sciences Small Grant Program
for New Investigators (R03).
Date: May 15, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Sheraton Hotel Reston, 11810 Sunrise Valley Dr., Herndon,
VA 20191.
Contact Person: Malaya Chatterjee, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6192, MSC 7804, Bethesda, MD
20892, (301) 806-2515, chatterm@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel Risk Prevention and Health Behavior AREA Review.
Date: May 15, 2017.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: John H. Newman, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3222, MSC 7808, Bethesda, MD
20892, (301) 435-0628, newmanjh@csr.nih.gov.
Name of Committee: Cell Biology Integrated Review Group, Nuclear
and Cytoplasmic Structure/Function and Dynamics Study Section.
Date: May 18, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Garden Inn Bethesda, 7301 Waverly Street,
Bethesda, MD 20814.
Contact Person: David Balasundaram, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5189, MSC 7840, Bethesda, MD
20892, 301-435-1022, balasundaramd@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: April 14, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-07931 Filed 4-19-17; 8:45 am]
BILLING CODE 4140-01-P
